Winson Cai - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Winson Cai

Showing results (11-20 of 14) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 14 results.

Cancer Cell|December 6, 2024

EZH2 inhibition enhances T cell immunotherapies by inducing lymphoma immunogenicity and improving T cell functionYusuke Isshiki, Xi Chen, Matt Teater, et al.

Nature Cancer|July 22, 2025

CAR-engineered lymphocyte persistence is governed by a FAS ligand-FAS autoregulatory circuitFei Yi, Tal Cohen, Natalie Zimmerman, et al.

The Journal of Experimental Medicine|June 26, 2026

Intravesical mesothelin-based CAR T cells targeting MUC16 effectively control bladder cancer in preclinical modelsParwiz Abrahimi, Jonathan F Khan, Alyssa Duren-Lubanski, et al.

Cancer Discovery|April 30, 2026

Development of CAR T cells Targeting a Surface RNA Binding Protein for the Treatment of Acute LeukemiasTakeshi Fujino, Jennifer Lewis, Bingyi Chen, et al.

Pageof 2

Search research articles

Showing results (11-20 of 14) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 14 results.

Cancer Cell|December 6, 2024

EZH2 inhibition enhances T cell immunotherapies by inducing lymphoma immunogenicity and improving T cell functionYusuke Isshiki, Xi Chen, Matt Teater, et al.

Nature Cancer|July 22, 2025

CAR-engineered lymphocyte persistence is governed by a FAS ligand-FAS autoregulatory circuitFei Yi, Tal Cohen, Natalie Zimmerman, et al.

The Journal of Experimental Medicine|June 26, 2026

Intravesical mesothelin-based CAR T cells targeting MUC16 effectively control bladder cancer in preclinical modelsParwiz Abrahimi, Jonathan F Khan, Alyssa Duren-Lubanski, et al.

Cancer Discovery|April 30, 2026

Development of CAR T cells Targeting a Surface RNA Binding Protein for the Treatment of Acute LeukemiasTakeshi Fujino, Jennifer Lewis, Bingyi Chen, et al.

Pageof 2